Viewing Study NCT02619526



Ignite Creation Date: 2024-05-06 @ 7:52 AM
Last Modification Date: 2024-10-26 @ 11:53 AM
Study NCT ID: NCT02619526
Status: UNKNOWN
Last Update Posted: 2018-02-05
First Post: 2015-11-25

Brief Title: Comparative Effects of Nebivolol and Carvedilol on Diastolic Function in the Elderly Heart Failure Patients
Sponsor: Dong-A University
Organization: Dong-A University

Study Overview

Official Title: Comparative Effects of Nebivolol and Carvedilol on Diastolic Function of the Left Ventricle in the Elderly Heart Failure Patients With Preserved Ejection Fraction Study Protocol for a Randomized Controlled Trial
Status: UNKNOWN
Status Verified Date: 2018-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Heart failure HF is a common and disabling condition in the elderly Randomized clinical trials and meta-analyses have clearly demonstrated that long-term use of β blockers improves the outcomes of patients with HF However limited data have been available on the treatment of HF with preserved ejection fraction EF in the elderly No study has specifically compared the relative effectiveness of carvedilol and nebivolol in treating HF in old age patients with preserved EF
Detailed Description: This trial is a prospective randomized open-label active controlled study designed to investigate effects of nebivolol and carvedilol on diastolic function of the left ventricle LV in the elderly HF patients with preserved EF

Patients will be included in the study if they had LVEF 40 NYHA functional class I II or III and clinical stability without hospital admission for HF in the preceding 3 months

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None